This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Centre for Cellular and Molecular Platforms. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Suresh Santhi Natesan: Innovator in Neuroinflammation Management
Introduction
Suresh Santhi Natesan is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of neuroinflammation and neurodegeneration. His innovative work focuses on methods and compositions that aim to manage these critical health issues.
Latest Patents
Suresh holds a patent titled "Methods and compositions for managing neuroinflammation and neurodegeneration." This patent describes a method of inhibiting neuroinflammation in neuron-surrounding cells. The process includes treating these cells with at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor, or a combination of both, to effectively inhibit neuroinflammation. Additionally, the patent outlines a method for managing neuroinflammation or neurodegenerative diseases in subjects in need, which involves administering these inhibitors. The composition mentioned in the patent includes at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor, optionally combined with a pharmaceutically acceptable excipient. Suresh has 1 patent to his name.
Career Highlights
Suresh Santhi Natesan is associated with the Centre for Cellular and Molecular Platforms, where he continues to advance his research and innovations. His work is pivotal in addressing neuroinflammatory conditions, which are increasingly recognized as significant contributors to various neurodegenerative diseases.
Collaborations
Suresh collaborates with notable colleagues such as Ravi Manjithaya and Shashank Rai. Their combined expertise enhances the research efforts at the Centre for Cellular and Molecular Platforms.
Conclusion
Suresh Santhi Natesan is a key figure in the field of neuroinflammation management, with a focus on innovative methods and compositions. His contributions are vital for advancing treatments for neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile